Cubist Systematic Strategies, LLC Homology Medicines, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.39 - $3.12 $39,114 - $87,796	28,140 New	28,140 $55,000
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $79,060 - $126,801	-30,408 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.64 - $7.78 $115,479 - $246,820	-31,725 Reduced 51.06%	30,408 $111,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $63,633 - $92,221	10,588 Added 20.54%	62,133 $489,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $310,300 - $496,893	51,545 New	51,545 $375,000

Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $33,000 - $55,078	-3,320 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $40,072 - $64,208	3,320 New	3,320 $50,000
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $31,853 - $48,147	-2,161 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $39,654 - $65,564	2,161 New	2,161 $42,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.